Bovie Medical (BVX) Misses Q1 EPS by 1c, Beats on Revenues; Offers FY18 Revenue Outlook

Bovie Medical (NYSE: BVX) reported Q1 EPS of ($0.03), $0.01 worse than the analyst estimate of ($0.02). Revenue for the quarter came in at $9.9 million versus the consensus estimate of $9.29 million.

2018 Outlook:

The Company is reaffirming its financial guidance, which was introduced on March 12, 2018.

For the fiscal year 2018, the Company continues to expect:

• Total revenue in the range of $41.0 million to $42.5 million, representing growth of 5% to 9% year-over-year. The Company expects total revenue growth to be driven by Advanced Energy sales growth in the range of approximately 40% to 45% year-over-year.
• The Company expects adjusted EBITDA in a range of $1.0 million to $1.5 million.

GUIDANCE:

Bovie Medical sees FY2018 revenue of $41-42.5 million, versus the consensus of $41.63 million.

For earnings history and earnings-related data on Bovie Medical (BVX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c